Condition
Fistulas Arteriovenous
Total Trials
6
Recruiting
2
Active
2
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Recruiting2
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04927156Recruiting
Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform
NCT04484220Not ApplicableCompleted
Ellipsys Vascular Access System Post Market Surveillance (PS) Study
NCT04226599Not ApplicableCompletedPrimary
A Safety and Efficacy Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With DissolveAV
NCT04626427Not ApplicableTerminated
The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation
NCT06480331Not ApplicableRecruitingPrimary
Radiation Free Fistuloplasty is the Way Forward
NCT04698512Completed
MAgicTouch™ Intervention Leap for Dialysis Access (MATILDA) Trial
Showing all 6 trials